Patients remain at the heart of the work we do every day. Patients’ health. Patients’ lives. Patients’ families and caregivers. They are what matters most to us, guiding us forward in our goal to deliver a completely different cancer therapy that could lengthen patient lives while maintaining their quality of life.
After receiving a glioblastoma diagnosis, Nikki Woolfolk felt relieved to learn the cause of her symptoms and began to take action.
Our Device Support Specialists (DSSs) work one-on-one with patients — educating them about the device, and providing technical support and personal contact with Novocure. Learn more about Amy Luton, one of our DSSs in Texas.
In the face of his glioblastoma diagnosis, Michael Davies strives to maintain normalcy and continue his personal and professional pursuits of working in the entertainment industry, and writing and performing stand-up comedy.
novocuretrial.com The science of Tumor Treating Fields extends beyond glioblastoma and mesothelioma. Novocure has ongoing or completed clinical trials investigating our therapy in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer.